Note 3 - Merger with Old Cytocom - Purchase Price (Details) - Cleveland BioLabs, Inc. [Member]	Jul. 27, 2021 USD ($) $ / shares shares
Number of shares of the combined company owned by Cleveland BioLabs, Inc. stockholders (in shares) | shares	15,478,945	[1]
Multiplied by the price per share of Cleveland BioLabs, Inc. common stock (in dollars per share) | $ / shares	$ 4.99	[2]
Total purchase price | $	$ 77,239,936

[1] Represents the number of shares of common stock of the combined company that Cleveland BioLabs, Inc. stockholders owned as of the closing of the Merger pursuant to the Merger Agreement. This amount is calculated as 15,478,945 shares of Cleveland BioLabs, Inc. common stock outstanding as of July 27, 2021.

[2] The fair value of Cleveland BioLabs, Inc. common stock used in determining the purchase price was $4.99.